Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.
Cellares
5 followers
Tango Therapeutics
3 followers
Dyno Therapeutics
4 followers
Odyssey Therapeutics
3 followers
Gilead Sciences
171 followers
Regeneron
143 followers
Illumina
81 followers
Agilent Technologies
89 followers
Verily Life Sciences
48 followers
Alexion Pharmaceuticals
49 followers
GRAIL
30 followers
Explore companies